Marksans Pharma Limited

Marksans Pharma Limitedverified

MARKSANS.BO

Price:

$183.95

Market Cap:

$83.37B

Marksans Pharma Limited, together with its subsidiaries, engages in the research and development, manufacturing, marketing, and sale of generic pharmaceutical formulations worldwide. The company offers products in the analgesics, benign prostatic hyperplasia, antidiabetic, epilepsy, anti-inflammatory, hyperparathyroidism, diabetes, antacids, neurology, cardiovascular, hormonal, oncology, gastroenterology, antidiabetic, pain management, gynecology, antifungal, antiulceratives, vitamins, dermatology, cephalosporins, injectables, anti-allergy, antibacterial, and hypertension therapeutic areas. Marksans Pharma Limited was incorporated in 1992 and is headquartered in Mumbai, India.

Industry

Drug Manufacturers - General

IPO Date

Stock Exchange

BSE

Ticker

MARKSANS.BO

The Enterprise Value as of December 2025 (TTM) for Marksans Pharma Limited (MARKSANS.BO) is 81.87B

According to Marksans Pharma Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 81.87B. This represents a change of -22.85% compared to the average of 106.12B of the last 4 quarters.

Marksans Pharma Limited (MARKSANS.BO) Historical Enterprise Value (quarterly & annually)

How has MARKSANS.BO Enterprise Value performed in the past?

The mean historical Enterprise Value of Marksans Pharma Limited over the last ten years is 30.10B. The current 81.87B Enterprise Value has changed 27.10% with respect to the historical average. Over the past ten years (40 quarters), MARKSANS.BO's Enterprise Value was at its highest in in the December 2024 quarter at 134.28B. The Enterprise Value was at its lowest in in the March 2020 quarter at 5.19B.

Quarterly (TTM)
Annual

Average

30.10B

Median

19.07B

Minimum

5.05B

Maximum

98.83B

Marksans Pharma Limited (MARKSANS.BO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Marksans Pharma Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 269.24%

Maximum Annual Enterprise Value = 98.83B

Minimum Annual Increase = -55.25%

Minimum Annual Enterprise Value = 5.05B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202598.83B41.12%
202470.03B162.80%
202326.65B63.81%
202216.27B-12.83%
202118.66B269.24%
20205.05B-55.25%
201911.30B-22.73%
201814.62B-27.44%
201720.14B3.40%
201619.48B-19.84%

Marksans Pharma Limited (MARKSANS.BO) Average Enterprise Value

How has MARKSANS.BO Enterprise Value performed in the past?

The current Enterprise Value of Marksans Pharma Limited (MARKSANS.BO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

65.17B

5-year avg

46.09B

10-year avg

30.10B

Marksans Pharma Limited (MARKSANS.BO) Enterprise Value vs. Peers

How is MARKSANS.BO’s Enterprise Value compared to its peers?

Marksans Pharma Limited’s Enterprise Value is less than Strides Pharma Science Limited (98.18B), less than Strides Pharma Science Limited (98.18B), greater than Aarti Pharmalabs Limited (65.41B), greater than Aarti Pharmalabs Limited (65.41B), less than Sanofi India Limited (96.99B), less than Sanofi India Limited (96.99B), greater than FDC Limited (67.26B), greater than FDC Limited (67.26B), greater than Yatharth Hospital & Trauma Care Services Limited (66.19B), greater than Yatharth Hospital & Trauma Care Services Limited (66.19B),

Build a custom stock screener for Marksans Pharma Limited (MARKSANS.BO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Marksans Pharma Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Marksans Pharma Limited (MARKSANS.BO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Marksans Pharma Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Marksans Pharma Limited's Enterprise Value?

What is the highest Enterprise Value for Marksans Pharma Limited (MARKSANS.BO)?

What is the 3-year average Enterprise Value for Marksans Pharma Limited (MARKSANS.BO)?

What is the 5-year average Enterprise Value for Marksans Pharma Limited (MARKSANS.BO)?

How does the current Enterprise Value for Marksans Pharma Limited (MARKSANS.BO) compare to its historical average?